Private Equity 3 Days

Last updated: June 7, 2026, 11:32 PM ET

Fundraising & Credit Deployments TJC announced a $8.5bn target for its seventh Resolute Fund, underscoring continued appetite for mid‑market North American buyouts as the firm eyes “lower‑middle‑market” platform opportunities. Across the Atlantic, Norvestor closed its €2bn flagship fund just three months after launch, raising €500 m above the prior vehicle and positioning the Nordic investor for a wave of tech‑focused exits. Meanwhile, CPP Investments expanded its forward‑flow agreement with Affirm to a maximum $2.2bn, committing $1.7bn over 24 months to fund $8bn of consumer‑loan originations, a move that reflects growing confidence in fintech credit pipelines. In the public markets, Advent and ADIA raised $2.43bn via Innio’s Nasdaq debut, with the gas‑engine maker surging 23% on first‑day trading, highlighting private‑equity‑backed IPOs as a viable liquidity channel for industrial assets.

Strategic Acquisitions & Carve‑outs Mill Point agreed to buy Total Safety Supplies & Solutions, adding an industrial‑products distributor that complements its existing safety‑equipment platform and expands its U.S. footprint. In Europe, Mutares secured an irrevocable offer from Reed Capital for Walor Precision Turning, marking the latest automotive‑component carve‑out and providing Reed with a precision‑manufacturing foothold in the German market. Private‑equity‑backed Renovus‑backed EducationDynamics acquired UK marketer Net Natives, a move that broadens the education‑services portfolio into digital enrollment. Finally, Consilium took a minority stake in Italy’s Twin Pack, giving the packaging specialist access to growth capital while allowing Consilium to diversify its industrial‑technology holdings.

High‑Profile Deals & Market Signals Allianz GI entered exclusive talks to acquire UOB Asset Management for up to $467 m, edging out rivals KKR and Amundi and signaling intensified competition for Asian asset‑management platforms. In the biotech sector, Oxford Bio Medica kept the door open for private‑equity bids after rebuffing EQT, indicating that valuation gaps remain a barrier but that a take‑private could still materialise under favourable terms. The ad‑tech space saw a Blackstone‑backed Liftoff debut at a $4.18bn valuation, with shares rising 9% on Nasdaq, illustrating how sponsor‑owned growth companies can command premium public‑market pricing. Conversely, Apollo withdrew its $2bn bid for Bodycote amid rising fraud concerns in M&A, a development that may prompt heightened due‑diligence standards across the private‑equity landscape.